Beecham Group

Last updated

The Beecham Group plc
Industry Pharmaceuticals
Founded1859
Defunct1989
FateMerged with SmithKline Beckman
SuccessorSmithKline Beecham (later GlaxoSmithKline, now Haleon)
Headquarters London, United Kingdom
Products Phenethicillin, Methicillin
Parent GlaxoSmithKline

The Beecham Group plc was a British pharmaceutical company. It was once a constituent of the FTSE 100 Index. Founded by Thomas Beecham who opened the first factory in St Helens, Lancashire in 1859, Beecham focused on marketing the business by advertising in newspapers and using a network of wholesale agents in northern England and in London, rapidly building up the business. [1] In August 1859 he created the slogan for Beecham's Pills: "Worth a guinea a box", considered to be the world's first advertising slogan, which helped the business become a global brand. [2]

Contents

Beecham, after having merged with American pharmaceutical company SmithKline Beckman to become SmithKline Beecham, merged with Glaxo Wellcome to become GlaxoSmithKline (GSK). GSK (and later, Haleon) still uses the Beechams brand name in the UK for its over-the-counter cold and flu relief products. [3]

Early history

Beecham began as the family business of Thomas Beecham (1820–1907). (Beecham would become the grandfather of music conductor Thomas Beecham, 1879–1961.) As a boy, Beecham worked as a shepherd, selling herbal remedies as a sideline.

He later became a travelling salesman or peddler full time. His first product was Beecham's Pills, a laxative, in 1842. [4] Subsequent success enabled him to open a shop in Wigan in 1847. [5] Beecham opened its first factory in 1859, in St Helens, Lancashire, for the rapid production of medicines. [4] In August 1859, Beechams created a slogan for Beecham's Pills: "Beechams Pills: Worth a guinea a box", which is considered to be the world's first advertising slogan. [2] First appearing in the St Helens Intelligencer, the Beechams adverts would appear in newspapers all over the world, helping the company become a global brand. [2] [6] The phrase was first said to be uttered by a satisfied lady purchaser from St Helens, the founder's home town. [6] [7] Under the founder's son, Sir Joseph Beecham, 1st Baronet (1848–1916), the business expanded, but remained a patent medicine company and engaged in little research.

Expansion and diversification

In 1924, Philip Ernest Hill (1873 - 1944), [8] [9] who made his money in real estate, acquired control of Beecham. [10] Under his leadership, the company bought up other companies for their various products and for their marketing infrastructure, acquiring the Lucozade glucose drink and Macleans (toothpaste) in 1938, and, at the same time, introducing the Ribena blackcurrant drink. [11] In 1938, it also bought the company selling Eno which had an extensive international presence. [10] [12] : 253  By purchasing the company manufacturing Brylcreem the following year, the company added hair products for men to its offerings. [4]

In 1943, Beecham decided to focus more on improving research and built Beecham Research Laboratories at Brockham Park, Surrey. In 1945, the company was renamed Beecham Group Ltd. [4] in 1953, Beecham acquired C.L. Bencard, which specialised in allergy vaccines. [4]

Beecham Research Laboratories opened a four acre site around October 1969 in Harlow in Essex, with 80 staff. [13] In 1997 this became the SmithKline Beecham New Frontiers Science Park.

Antibiotics

In 1959, Brockham Park became famous when Beecham scientists there discovered the penicillin nucleus, 6-APA (6-aminopenicillanic acid); [14] This discovery allowed Beecham, working in tandem with Bristol-Myers, to synthesize a number of new semisynthetic penicillins. Beecham marketed Broxil (phenethicillin), followed shortly by the more potent Celbenin (methicillin), which was active against Staphylococcus aureus . The group continued to focus on pharmaceutical development, producing further semi-synthetic penicillins. However, when Penbritin (ampicillin) came on the market in 1961, Beecham's facilities were soon inadequate for the worldwide demand for the drug. A 35-acre (140,000 m2) complex at Worthing came on line in the early 1960s, to produce phenethicillin, followed by the ability to produce 6-APA, the base for semisynthetic penicillins.

The company continued to add products, and acquire other companies, through the 1970s and 1980s. In 1971, the S. E. Massengill Company was acquired. Beecham launched Amoxil (amoxicillin) in 1972, which went on to become one of the most widely prescribed antibiotics. [4]

In 1973, Aqua-fresh toothpaste was launched, and in 1977, the Sucrets brand was acquired. Augmentin, an antibiotic used to treat an array of bacterial infections, was introduced in 1981. [4] J.B. Williams Co., Inc. was acquired from Nabisco in 1982 [15] for US$100 million (approximately £59 million), [16] which included brands Aqua Velva, Geritol, and Sominex − the U.S. formulation − along with others. [17]

Later history

In 1986, the Beecham Group sold its numerous soft drink brands including Tango, Top Deck, Corona, and Quosh, as well as the UK franchises for Pepsi and 7 Up, to Britvic. [18] The same year, Beecham acquired Norcliff Thayer from Revlon.

As the turn of the century approached, there were more significant mergers. In 1989, The Beecham Group plc and SmithKline Beckman merged to form SmithKline Beecham plc. [4] [19] In 2000, SmithKline Beecham and GlaxoWellcome merged to form GlaxoSmithKline. [20]

A history of the company, Beechams, 1848–2000: From Pills to Pharmaceuticals, written by Thomas Anthony Buchanan Corley, was published in 2011. [21]

Products

Consumer healthcare

Pharmaceuticals

See also

Related Research Articles

<span class="mw-page-title-main">Ribena</span> Blackcurrant-based drink

Ribena is a brand of blackcurrant-based soft drink, and fruit drink concentrate designed to be mixed with water. It is available in bottles, cans and multi-packs. Originally of English origin, it was produced by the pharmaceutical company GlaxoSmithKline (GSK) until 2013, when the brand was sold to Japanese beverage conglomerate Suntory.

<span class="mw-page-title-main">GSK plc</span> UK healthcare company

GSK plc is a British multinational pharmaceutical and biotechnology company with global headquarters in London. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm.

<span class="mw-page-title-main">Horlicks</span> Sweet malted milk hot drink powder

Horlicks is a sweet malted milk hot drink powder developed by founders James and William Horlick. It was first sold as "Horlick's Infant and Invalids Food", soon adding "aged and travellers" to their label. In the early 20th century, it was sold as a powdered meal replacement drink mix.

<span class="mw-page-title-main">Geritol</span> Dietary supplement brand

Geritol is a United States trademarked name for various dietary supplements, past and present. Geritol is a brand name for several vitamin complexes plus iron or multimineral products in both liquid form and tablets, containing from 9.5 to 18 mg of iron per daily dose. The name conveys a connection with aging, as in "geriatric". The product has been promoted from almost the beginning of the mass media era as a cure for "iron-poor tired blood".

Lucozade is a British brand of soft drinks and energy drinks manufactured and marketed by the Japanese company Suntory. Created as "Glucozade" in the UK in 1927 by a Newcastle pharmacist, William Walker Hunter, it was acquired by the British pharmaceutical company Beecham's in 1938 and sold as Lucozade, an energy drink for the sick. Its advertising slogan was "Lucozade aids recovery". It was sold mostly in pharmacies up until the 1980s before it was more readily available as a sports drink in shops across the UK.

<span class="mw-page-title-main">Brockham</span> Human settlement in England

Brockham is a village and civil parish in the Mole Valley district of Surrey, England. It is approximately 1.5 miles (2.4 km) east of Dorking and 4 miles (6.4 km) west of Reigate. The village lies south of Box Hill, with the River Mole flowing west through the village. At the 2011 census, it had a population of 2,868.

<span class="mw-page-title-main">Ticarcillin</span> Antibiotic medication

Ticarcillin is a carboxypenicillin. It can be sold and used in combination with clavulanate as ticarcillin/clavulanic acid. Because it is a penicillin, it also falls within the larger class of β-lactam antibiotics. Its main clinical use is as an injectable antibiotic for the treatment of Gram-negative bacteria, particularly Pseudomonas aeruginosa and Proteus vulgaris. It is also one of the few antibiotics capable of treating Stenotrophomonas maltophilia infections.

<span class="mw-page-title-main">Oxacillin</span> Chemical compound

Oxacillin is a narrow-spectrum beta-lactam antibiotic of the penicillin class developed by Beecham.

<span class="mw-page-title-main">Beecham's Pills</span>

Beecham's Pills were a laxative first marketed about 1842 in Wigan, Lancashire. They were invented by Thomas Beecham (1820–1907), grandfather of the conductor Sir Thomas Beecham (1879–1961). The British pharmaceutical firm, established in 1859 as Beechams, became a global brand, and in the year it was founded produced the first advertising slogan.

<span class="mw-page-title-main">Smith, Kline & French</span> First Predecessor company of GlaxoSmithKline

Smith, Kline & French (SKF) was an American pharmaceutical company.

Reliant Pharmaceuticals was a company purchased by GlaxoSmithKline in December 2007 for $1.65B. Co-founded by Joseph J. Krivulka.

GlaxoSmithKline Pakistan is a Pakistani pharmaceutical company which is a subsidiary of British company GSK. It is the largest pharmaceutical company in Pakistan.

<span class="mw-page-title-main">Block Drug</span> Pharmaceutical company

Block Drug Company was a pharmaceutical company based in Jersey City, New Jersey, United States, that specialized in dental care products. Its most popular products included Polident denture cleanser, Poli-Grip denture adhesive, Dentu-Creme denture toothpaste, Nytol sleeping pill, Tegrin medicated shampoo for psoriasis, Lava hand soaps, Beano and Phazyme anti-gas products, Balmex diaper rash ointments, and Sensodyne desensitizing toothpaste.

Thomas Beecham was a British businessman who founded Beechams, a large pharmaceutical business. In 1859, he focused on marketing the business by advertising in newspapers and using a network of wholesale agents in northern England and in London, rapidly building up the business. In August 1859, he created the slogan for Beecham's Pills: "Worth a guinea a box", which is considered to be the world's first advertising slogan, helping the company become a global brand.

The pharmaceutical industry in the United Kingdom directly employs around 73,000 people and in 2007 contributed £8.4 billion to the UK's GDP and invested a total of £3.9 billion in research and development. In 2007 exports of pharmaceutical products from the UK totalled £14.6 billion, creating a trade surplus in pharmaceutical products of £4.3 billion.

<span class="mw-page-title-main">Study 329</span> Scientific article

Study 329 was a clinical trial which was conducted in North America from 1994 to 1998 to study the efficacy of paroxetine, an SSRI anti-depressant, in treating 12- to 18-year-olds diagnosed with major depressive disorder. Led by Martin Keller, then professor of psychiatry at Brown University, and funded by the British pharmaceutical company SmithKline Beecham—known since 2000 as GlaxoSmithKline (GSK)—the study compared paroxetine with imipramine, a tricyclic antidepressant, and placebo. SmithKline Beecham had released paroxetine in 1991, marketing it as Paxil in North America and Seroxat in the UK. The drug attracted sales of $11.7 billion in the United States alone from 1997 to 2006, including $2.12 billion in 2002, the year before it lost its patent.

<span class="mw-page-title-main">Emma Walmsley</span> British businesswoman

Dame Emma Natasha Walmsley is the chief executive officer (CEO) of GlaxoSmithKline. She succeeded Sir Andrew Witty, who retired in March 2017. Before GSK, she worked for L'Oréal for 17 years, and was a non-executive director of Diageo until September 2016. She grew up in Barrow-in-Furness, Cumbria, England.

<span class="mw-page-title-main">New Frontiers Science Park</span> Science park, former research centre in Harlow, Essex

The New Frontiers Science Park is a science park in Essex, on a redeveloped research site of GlaxoSmithKline (GSK).

References

  1. ↑ "The man behind the eponymous Beechams Powders gets blue plaque". The Business Magazine. Retrieved 8 November 2023.
  2. 1 2 3 "Anniversary of the first ad slogan". The Herald. 5 August 2019.
  3. ↑ "Get powerful relief from cold & flu symptoms with Beechams". beechams.co.uk. Retrieved 7 May 2012.
  4. 1 2 3 4 5 6 7 8 "Our history – GSK" . Retrieved 19 November 2016.
  5. ↑ Thomas Beecham at Oxford Dictionary of National Biography
  6. 1 2 "When Beecham put St Helens on the map". St Helen's Star. Retrieved 5 November 2023.
  7. ↑ Ratcliffe, Susan (2011). Oxford Treasury of Sayings and Quotations. Oxford University Press. p. 478.
  8. ↑ "A capsulated history of Beecham - Let's Look Again". 24 November 2017.
  9. ↑ "Philip E. Hill".
  10. 1 2 Tedlow, Richard S.; Jones, Geoffrey G. (2014). The Rise and Fall of Mass Marketing (RLE Marketing) Volume 25 of Routledge Library Editions: Marketing. Routledge. pp. 110–111. ISBN   9781317663010.
  11. ↑ "SmithKline Beecham: History" Archived 20 July 2013 at the Wayback Machine , History of Advertising Trust
  12. ↑ Wilkins, Mira (2004). The history of foreign investment in the United States, 1914-1945 . Cambridge, Massachusetts: Harvard University Press. ISBN   9780674045187.
  13. ↑ Herts and Essex Observer Friday 15 August 1969, page 12
  14. ↑ Batchelor, F.R.; Doyle, F. P.; Naylor, J. H. C.; Rolinson, G. N. (1959). "Synthesis of Penicillin: 6-Aminopenicillanic Acid in Penicillin Fermentations" (PDF). Nature. 183 (4656): 257–8. Bibcode:1959Natur.183..257B. doi:10.1038/183257b0. PMID   13622762. S2CID   4268993.
  15. ↑ "Nabisco selling Williams subsidiary" . The Miami News . 14 September 1982. p. 10A – via Newspapers.com.
  16. ↑ Northedge, Richard (14 September 1982). "Beecham puts up £59m cash for U.S. group". The Daily Telegraph . No. 39580. p. 17 – via Newspapers.com.
  17. ↑ Moskowitz, Mlton (6 July 1982). "Dissolving A Poor Team: Nabisco Looks To Sell" . Lancaster New Era . Vol. 105, no. 32989. p. 30 – via Newspapers.com.
  18. ↑ "Carbonated drinks: a report on the supply by manufacturers of carbonated drinks in the United Kingdom, Chapter 8 para 8.51" (PDF). Archived from the original (PDF) on 29 July 2008. Retrieved 24 July 2008.
  19. ↑ "Profile: SmithKline Beecham". BBC. 18 December 2000.
  20. ↑ "The Glaxo SmithKline merger". BBC News. 17 January 2000.
  21. ↑ Corley, T. A. B. (29 March 2011). Beechams, 1848-2000: from Pills to Pharmaceuticals. Lancaster: Crucible Books. ISBN   978-1-905472-14-7.
  22. ↑ "Beechams Powders - Summary of Product Characteristics (SPC)". Medicines.org. Retrieved 19 November 2016. Beecham's Powders is a cold and flu remedy sold in the UK. The medicine is a white powder wrapped in a paper sachet. The powder is mixed with water and then drunk in suspension. The active ingredients are caffeine and aspirin, the effects of taking this remedy are the lowering of body temperature, reduction in aches and pains, along with a mild return of energy. This medicine is often used by people who need to continue working despite having a cold or mild flu.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.